Nevro Corp. (NVRO) recently received CE Mark Certification in Europe for its HFX iQ spinal cord stimulation (SCS) system.  The company can now market HFX iQ in all countries that recognize this certification. Nevro plans to launch the HFX iQ system in select European countries starting first-quarter 2025.With the latest CE Mark Certification for HFX iQ, Nevro marks a milestone in its strategic journey to drive market penetration through data-backed, AI-powered SCS therapy.Likely Trend of NVRO Stock Followin ...